News Releases

Date Title and Summary View
Nov 06, 2018
Johnson & Johnson to Participate in the Credit Suisse 27th Annual Healthcare Conference
NEW BRUNSWICK, N.J. , Nov. 6, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 27th Annual Healthcare Conference on Tuesday, November 13 th , at The Phoenician in Scottsdale, AZ.  Scott White , Company Group Chairman, North America Pharmaceuticals will
Nov 01, 2018
Oct 30, 2018
Oct 29, 2018
Johnson & Johnson Consumer Aligns To Big Goals In Environmental Sustainability, Signs New Plastics Economy Global Commitment
NEW BRUNSWICK, N.J. , Oct. 29, 2018 /PRNewswire/ -- Johnson & Johnson Consumer, Inc. today announced the company is joining an ambitious effort to move the world closer to a circular economy in which plastic never becomes waste. Together with the Ellen MacArthur Foundation , the UN Environment
Oct 26, 2018
Court Issues Ruling in ZYTIGA® Patent Infringement Litigation
NEW BRUNSWICK, N.J. , Oct. 26, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that the United States District Court , District of New Jersey has issued a ruling invalidating all asserted claims of U.S. Patent No. 8,822,438 for ZYTIGA ® (abiraterone acetate).
Oct 23, 2018
Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd.
NEW BRUNSWICK, N.J. , Oct. 23, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) today announced that they have agreed with Ci:z Holdings Co., Ltd. (TYO: 4924) (the "Company"), a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic
Oct 18, 2018
Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2018
NEW BRUNSWICK, N.J. , Oct. 18, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2018 of $0.90 per share on the company's common stock.  The dividend is payable on December 11, 2018 to shareholders
Oct 16, 2018
Johnson & Johnson Reports 2018 Third-Quarter Results:
NEW BRUNSWICK, N.J. , Oct. 16, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) today announced sales of $20.3 billion for the third quarter of 2018, an increase of 3.6% as compared to the third quarter of 2017. Operational sales results increased 5.5%, partially offset by the negative impact of
Oct 10, 2018
Oct 09, 2018
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.